These results suggest that the dysregulation of SPRYD7 is a common event in CRC, i.e., not restricted to the KM12 cell model of CRC metastasis, being mostly associated with the metastatic capacity of CRC cell lines. Here, SPRYD7 is linked to colorectal carcinoma.